Cargando…

Development and Validation of the HIV-CARDIO-PREDICT Score to Estimate the Risk of Cardiovascular Events in HIV-Infected Patients

Importance: Commonly used risk assessment tools for cardiovascular disease might not be accurate for HIV-infected patients. Objective: We aimed to develop a model to accurately predict the 10-year cardiovascular disease (CV) risk of HIV-infected patients. Design: In this retrospective cohort study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karanika, Styliani, Karantanos, Theodoros, Carneiro, Herman, Assoumou, Sabrina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953852/ https://www.ncbi.nlm.nih.gov/pubmed/36831190 http://dx.doi.org/10.3390/cells12040523

Ejemplares similares

976. Development and Validation of a Risk Score for Predicting Cardiovascular Events in HIV-Infected Patients
por: Karanika, Styliani, et al.
Publicado: (2019)

Immune response after laparoscopic colectomy for cancer: a review
por: Karanika, Styliani, et al.
Publicado: (2013)

Human Immunodeficiency Virus and Clonal Hematopoiesis
por: Vorri, Stamatia C., et al.
Publicado: (2023)

Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistance
por: Karanika, Styliani, et al.
Publicado: (2014)

DNA damage response and prostate cancer: defects, regulation and therapeutic implications
por: Karanika, Styliani, et al.
Publicado: (2014)

HIV/Tuberculosis Coinfection in Pregnancy and the Postpartum Period
por: Yilma, Addis, et al.
Publicado: (2023)

Cardio-renal and cardio-hepatic interactions predict cardiovascular events in elderly patients with heart failure
por: Okano, Takahiro, et al.
Publicado: (2020)

Predictive Value of the Cardio‐Ankle Vascular Index for Cardiovascular Events in Patients at Cardiovascular Risk
por: Miyoshi, Toru, et al.
Publicado: (2021)

GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
por: Karanika, Styliani, et al.
Publicado: (2015)

439. Anal Dysplasia Screening Cascade within a Single-Center Outpatient HIV Clinic
por: Modlin, Chelsea, et al.
Publicado: (2022)

Cardio-Ankle Vascular Index as an Arterial Stiffness Marker Improves the Prediction of Cardiovascular Events in Patients without Cardiovascular Diseases
por: Okamoto, Yuko, et al.
Publicado: (2022)

Estimating Cardiovascular Risk in HIV-Infected Patients
por: Bittencourt, Marcio Sommer
Publicado: (2020)

Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction
por: Astarita, Anna, et al.
Publicado: (2021)

Development and validation of a scoring system for the prediction of HIV drug resistance in Hubei province, China
por: Yan, Jisong, et al.
Publicado: (2023)

Impact of a cardio‐oncology unit on prevention of cardiovascular events in cancer patients
por: Cuomo, Alessandra, et al.
Publicado: (2022)

Cardio-Metabolic Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir)
por: Reyskens, Kathleen M. S. E., et al.
Publicado: (2013)

The data‐collection on adverse effects of anti‐HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV
por: Anikpo, Ifedioranma, et al.
Publicado: (2021)

Prediction of cardiovascular adverse events in newly diagnosed multiple myeloma: Development and validation of a risk score prognostic model
por: Yuan, Shuai, et al.
Publicado: (2023)

Correction: Cardio-Metabolic Effects of HIV Protease Inhibitors (Lopinavir/Ritonavir)
por: Reyskens, Kathleen M. S. E., et al.
Publicado: (2013)

Comparison of Risk Category Predictions of Framingham Risk Score (FRS), Atherosclerotic Cardiovascular Disease Risk Score (ASCVD), Systematic Coronary Risk Evaluation (SCORE) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) in HIV Infected Patients
por: Korten, Volkan, et al.
Publicado: (2017)

Validation of the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) chronic kidney disease risk score in HIV‐infected patients in the USA
por: Mills, AM, et al.
Publicado: (2020)

Developing and Validating Risk Scores for Predicting Major Cardiovascular Events Using Population Surveys Linked with Electronic Health Insurance Records
por: Chang, Hsing-Yi, et al.
Publicado: (2022)

Development and validation of a 1-km cardio-trekking test to estimate cardiorespiratory fitness in healthy adults
por: Eisenberger, Laura, et al.
Publicado: (2022)

Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events Trial
Publicado: (2015)

Cardio-Oncology: mechanisms of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2018)

Cardio-oncology: management of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2019)

Screening for cardio-metabolic risk factors in the Romanian cohort of HIV-positive patients
por: Streinu-Cercel, Anca, et al.
Publicado: (2014)

Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV
por: Bernardino, Jose I., et al.
Publicado: (2023)

Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial
por: Wheeler, David C., et al.
Publicado: (2014)

Validation of 2006 WHO Prediction Scores for True HIV Infection in Children Less than 18 Months with a Positive Serological HIV Test
por: Peltier, Cécile Alexandra, et al.
Publicado: (2009)

The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular Events
por: Wandeler, Gilles, et al.
Publicado: (2016)

Correlation Between CardioMEMS and HeartLogic in Predicting Heart Failure Events
por: Kobrossi, Semaan, et al.
Publicado: (2020)

Marijuana Use Impacts Midlife Cardiovascular Events in HIV-Infected Men
por: Lorenz, David R., et al.
Publicado: (2017)

Community‐Acquired Pneumonia and Risk of Cardiovascular Events in People Living With HIV
por: Zifodya, Jerry S., et al.
Publicado: (2020)

Cardiovascular events in delayed presentation of HIV: the prospective PISCIS cohort study
por: Martín-Iguacel, Raquel, et al.
Publicado: (2023)

An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women
por: Balkus, Jennifer E., et al.
Publicado: (2016)

Prevention of cardiovascular disease guided by total risk estimations − challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular Pharmacology and Drug Therapy
por: Zannad, Faiez, et al.
Publicado: (2012)

Assessment of Arterial Stiffness by Cardio-Ankle Vascular Index for Prediction of Five-Year Cardiovascular Events After Coronary Artery Bypass Surgery
por: Sumin, Alexei N., et al.
Publicado: (2021)

Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Côte d’Ivoire
por: Mensah, Keitly, et al.
Publicado: (2020)

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ot6570oilmequ1idbvqrpqpn3q